These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 8642214)
41. Proliferative response of synovial fluid mononuclear cells of patients with rheumatoid arthritis to mycobacterial 65 kDa heat shock protein and its association with HLA-DR+.gamma delta+ T cells. Kogure A; Miyata M; Nishimaki T; Kasukawa R J Rheumatol; 1994 Aug; 21(8):1403-8. PubMed ID: 7983638 [TBL] [Abstract][Full Text] [Related]
42. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts. Mathew JM; Muthukkaruppan V Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417 [TBL] [Abstract][Full Text] [Related]
43. Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients. Ohman R; Walford C; Converse P; Ridell M Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):320-2. PubMed ID: 2071990 [No Abstract] [Full Text] [Related]
44. Immunological reactions to mycobacterial proteins in the spectrum of leprosy. Rada EM; Aranzazu N; Convit J Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162 [No Abstract] [Full Text] [Related]
45. IL-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy. Launois P; Vandenbussche P; M'Bayame NN; Drowart A; Van Vooren JP; Sarthou JL; Millan J; Huygen K Cell Immunol; 1993 May; 148(2):283-90. PubMed ID: 8495494 [TBL] [Abstract][Full Text] [Related]
46. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Chattree V; Khanna N; Rao DN Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060 [TBL] [Abstract][Full Text] [Related]
47. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284 [TBL] [Abstract][Full Text] [Related]
48. Cellular immune responses to mycobacterial heat shock proteins in Nepali leprosy patients and controls. Roche PW; Theuvenet WJ; Britton WJ Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):36-43. PubMed ID: 1602192 [TBL] [Abstract][Full Text] [Related]
49. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597 [TBL] [Abstract][Full Text] [Related]
50. IgG subclass recognition pattern in leprosy: recognition of M. leprae antigens by IgG1 and IgG3 antibodies is distinct across the disease spectrum. Kifayet A; Hussain R Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):69-78. PubMed ID: 8627117 [TBL] [Abstract][Full Text] [Related]
51. Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Adams E; Britton W; Morgan A; Sergeantson S; Basten A Scand J Immunol; 1994 Jun; 39(6):588-96. PubMed ID: 7516574 [TBL] [Abstract][Full Text] [Related]
52. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients. Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754 [TBL] [Abstract][Full Text] [Related]
53. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors. Mohagheghpour N; Gelber RR; Engleman EG J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952 [TBL] [Abstract][Full Text] [Related]
54. Definition of a human suppressor T-cell epitope. Mutis T; Cornelisse YE; Datema G; van den Elsen PJ; Ottenhoff TH; de Vries RR Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9456-60. PubMed ID: 7524076 [TBL] [Abstract][Full Text] [Related]
57. Recognition of Mycobacterium leprae antigens with antibodies present in sera from patients with lepromatous leprosy. Islas-Rodríguez AE; Guillén-Vargas CM; Fafutis-Morris M; Alfaro-Bustamante F; Morales-Ortíz R; Gonzalez-Mendoza A; Estrada-Parra I Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):245-9. PubMed ID: 7690388 [TBL] [Abstract][Full Text] [Related]
58. Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3. van Eden W; Elferink BG; de Vries RR; Leiker DL; van Rood JJ Clin Exp Immunol; 1984 Jan; 55(1):140-8. PubMed ID: 6362932 [TBL] [Abstract][Full Text] [Related]
59. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774 [TBL] [Abstract][Full Text] [Related]
60. A 28-kDa protein from Mycobacterium leprae is a target of the human antibody response in lepromatous leprosy. Cherayil BJ; Young RA J Immunol; 1988 Dec; 141(12):4370-5. PubMed ID: 3058804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]